Evaluating IDA
Vanflyta
INJ Administration
100

This is the number of key indices for evaluating IDA

What is 3

100

This is the mutation that Vanflyta acts on

FLT3-ITD

100

This is the number of doses needed for a full course of INJ

What is 2

200

Production of this requires sufficient levels of stored iron and adequate TSAT

What is Hemoglobin (Hb)

200

This is the age range for the Quantum-First clinical trial

18-75

200

This is the minimum amount of time over which INJ should be infused

What is 15 min 
300

This is another test that can be run for testing for IDA. It's values were not, however, measured in pivotal trials for Injecatfer

What is TIBC (Total Iron-binding capacity)

300

This is the dosing for Vanflyta during days 1-14 of the maintenance phase 

26.5mg orally once daily 

300

This is the other method of INJ administration

What is IV Push

400

The lowest normal Hb value for women (adults)

What is 12.0

400

This is the estimated number of people living with AML in the United States

70,000

400

INJ is available as a ____mg single-dose vial and as a ___mg single-dose vial

750 and 100

500

The lowest normal TSAT value in pediatrics for males

What is 15%

500

This is the primary endpoint in the Quantum-First study

(OS)--Overall Survival

500

This is the number of clinical trials used to determine the appropriate dose for a full course of INJ

Seven 

M
e
n
u